• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于模型的方法来评估免疫检查点抑制剂诱发自身免疫性心肌炎的风险。

A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis.

作者信息

van der Vegt Solveig A, Wang Ying-Jie, Polonchuk Liudmila, Wang Ken, Waters Sarah L, Baker Ruth E

机构信息

Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford, United Kingdom.

Department of Cardiovascular Medicine, Radcliffe Department of Medicine, Wellcome Centre of Human Genetics, University of Oxford, Oxford, United Kingdom.

出版信息

Front Pharmacol. 2022 Sep 26;13:966180. doi: 10.3389/fphar.2022.966180. eCollection 2022.

DOI:10.3389/fphar.2022.966180
PMID:36249751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9555336/
Abstract

Immune checkpoint inhibitors (ICIs), as a novel immunotherapy, are designed to modulate the immune system to attack malignancies. Despite their promising benefits, immune-related adverse events (IRAEs) may occur, and incidences are bound to increase with surging demand of this class of drugs in treating cancer. Myocarditis, although rare compared to other IRAEs, has a significantly higher fatal frequency. Due to the overwhelming complexity of the immune system, this condition is not well understood, despite the significant research efforts devoted to it. To better understand the development and progression of autoimmune myocarditis and the roles of ICIs therein, we suggest a new approach: mathematical modelling. Mathematical modelling of myocarditis has enormous potential to determine which parts of the immune system are critical to the development and progression of the disease, and therefore warrant further investigation. We provide the immunological background needed to develop a mathematical model of this disease and review relevant existing models of immunology that serve as the mathematical inspiration needed to develop this field.

摘要

免疫检查点抑制剂(ICIs)作为一种新型免疫疗法,旨在调节免疫系统以攻击恶性肿瘤。尽管它们具有显著的益处,但免疫相关不良事件(IRAEs)仍可能发生,并且随着这类药物在治疗癌症方面的需求激增,其发生率必然会增加。心肌炎虽然与其他IRAEs相比较为罕见,但其致死率明显更高。由于免疫系统极其复杂,尽管对此投入了大量研究工作,但这种情况仍未得到充分了解。为了更好地理解自身免疫性心肌炎的发生发展以及ICIs在其中的作用,我们提出一种新方法:数学建模。心肌炎的数学建模在确定免疫系统的哪些部分对疾病的发生发展至关重要方面具有巨大潜力,因此值得进一步研究。我们提供了建立该疾病数学模型所需的免疫学背景,并回顾了相关的现有免疫学模型,这些模型为该领域的发展提供了数学灵感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/4ce16c47b86b/fphar-13-966180-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/7ca48ba9d9dc/fphar-13-966180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/4f0bf8f9e2fe/fphar-13-966180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/b0705ee3d7d8/fphar-13-966180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/690b2a8669f7/fphar-13-966180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/be438bb5dfc4/fphar-13-966180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/bd7aeab533dd/fphar-13-966180-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/4ce16c47b86b/fphar-13-966180-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/7ca48ba9d9dc/fphar-13-966180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/4f0bf8f9e2fe/fphar-13-966180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/b0705ee3d7d8/fphar-13-966180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/690b2a8669f7/fphar-13-966180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/be438bb5dfc4/fphar-13-966180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/bd7aeab533dd/fphar-13-966180-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/487d/9555336/4ce16c47b86b/fphar-13-966180-g007.jpg

相似文献

1
A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis.一种基于模型的方法来评估免疫检查点抑制剂诱发自身免疫性心肌炎的风险。
Front Pharmacol. 2022 Sep 26;13:966180. doi: 10.3389/fphar.2022.966180. eCollection 2022.
2
Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors.自身免疫性心肌炎的数学建模及免疫检查点抑制剂的作用
J Theor Biol. 2022 Mar 21;537:111002. doi: 10.1016/j.jtbi.2021.111002. Epub 2022 Jan 8.
3
[Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].免疫检查点抑制剂相关心肌炎的研究进展
Zhongguo Fei Ai Za Zhi. 2021 Sep 20;24(9):668-672. doi: 10.3779/j.issn.1009-3419.2021.102.27. Epub 2021 Sep 15.
4
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity.免疫疗法治疗伴有自身免疫的恶性肿瘤患者。
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2019-000356.
5
An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors.一种新兴的心脏毒性:免疫检查点抑制剂引起的急性心肌炎。
Biomolecules. 2021 May 22;11(6):785. doi: 10.3390/biom11060785.
6
Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.多器官免疫相关不良事件是癌症患者免疫检查点抑制剂相关性心肌炎的危险因素:一项多中心研究。
Front Immunol. 2022 Jul 18;13:879900. doi: 10.3389/fimmu.2022.879900. eCollection 2022.
7
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.免疫检查点抑制剂相关性心肌炎合并肌炎/重症肌无力重叠综合征:病例系统综述。
Oncologist. 2021 Dec;26(12):1052-1061. doi: 10.1002/onco.13931. Epub 2021 Aug 25.
8
Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.免疫检查点抑制剂诱导的伴重症肌无力样误导性表现的肌炎/心肌炎:重症监护病房的病例系列
J Clin Med. 2022 Sep 23;11(19):5611. doi: 10.3390/jcm11195611.
9
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.免疫检查点抑制剂治疗患者的流感疫苗接种和心肌炎。
J Immunother Cancer. 2019 Feb 22;7(1):53. doi: 10.1186/s40425-019-0535-y.
10
Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?免疫检查点抑制剂相关的血液学免疫不良反应,如何管理?
Eur J Cancer. 2019 Nov;122:72-90. doi: 10.1016/j.ejca.2019.07.014. Epub 2019 Oct 18.

引用本文的文献

1
Optimal Control of Immune Checkpoint Inhibitor Therapy in a Heart-Tumour Model.心脏肿瘤模型中免疫检查点抑制剂治疗的最优控制
Bull Math Biol. 2025 Aug 11;87(9):127. doi: 10.1007/s11538-025-01468-4.
2
Can the Discovery of High-Impact Diagnostics Be Improved by Matching the Sampling Rate of Clinical Diagnostics to the Frequency Domain of Diagnostic Information?通过使临床诊断的采样率与诊断信息的频域相匹配,能否改进高影响力诊断方法的发现?
Cancers (Basel). 2025 Apr 22;17(9):1387. doi: 10.3390/cancers17091387.
3
Risk factors for cardiovascular adverse events from immune checkpoint inhibitors.

本文引用的文献

1
Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration.未成熟和成熟树突状细胞的特性:表型、形态、吞噬作用及迁移
RSC Adv. 2019 Apr 10;9(20):11230-11238. doi: 10.1039/c9ra00818g. eCollection 2019 Apr 9.
2
Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors.自身免疫性心肌炎的数学建模及免疫检查点抑制剂的作用
J Theor Biol. 2022 Mar 21;537:111002. doi: 10.1016/j.jtbi.2021.111002. Epub 2022 Jan 8.
3
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.
免疫检查点抑制剂导致心血管不良事件的风险因素。
Front Oncol. 2023 Apr 28;13:1104888. doi: 10.3389/fonc.2023.1104888. eCollection 2023.
心肌炎中的室性心律失常:特征与心肌炎症的关系。
J Am Coll Cardiol. 2020 Mar 10;75(9):1046-1057. doi: 10.1016/j.jacc.2020.01.036.
4
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.免疫检查点抑制剂相关性心肌炎:病理生理特征、诊断与治疗
J Am Heart Assoc. 2020 Jan 21;9(2):e013757. doi: 10.1161/JAHA.119.013757.
5
Heart non-specific effector CD4 T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis.心脏非特异性效应性 CD4 T 细胞可预防实验性自身免疫性心肌炎的炎症后纤维化和心功能障碍。
Basic Res Cardiol. 2019 Dec 20;115(1):6. doi: 10.1007/s00395-019-0766-6.
6
Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages.超越 T 细胞:理解 PD-1/PD-L1 在肿瘤相关巨噬细胞中的作用。
J Immunol Res. 2019 Nov 4;2019:1919082. doi: 10.1155/2019/1919082. eCollection 2019.
7
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy.微生物衍生肽模拟物引发致命性炎症性心肌病。
Science. 2019 Nov 15;366(6467):881-886. doi: 10.1126/science.aav3487.
8
CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart.心脏免疫疗法:经工程改造用于治疗纤维化心脏的T细胞
Mol Ther. 2019 Nov 6;27(11):1869-1871. doi: 10.1016/j.ymthe.2019.09.021. Epub 2019 Oct 1.
9
Cardiotoxicity from immune checkpoint inhibitors.免疫检查点抑制剂引起的心脏毒性。
Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. eCollection 2019 Dec.
10
Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to.癌症的数学模型:何时预测新疗法,以及何时不预测。
Bull Math Biol. 2019 Oct;81(10):3722-3731. doi: 10.1007/s11538-019-00640-x. Epub 2019 Jul 23.